CanSino Biologics Inc.
CASBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,206,923 | $5,165,394 | $14,245,708 | $36,152,024 |
| - Cash | $1,556,463 | $2,046,998 | $3,394,824 | $5,456,873 |
| + Debt | $2,013,373 | $2,700,341 | $2,700,630 | $1,374,818 |
| Enterprise Value | $7,663,833 | $5,818,737 | $13,551,514 | $32,069,969 |
| Revenue | $824,884 | $345,182 | $1,031,041 | $4,299,702 |
| % Growth | 139% | -66.5% | -76% | – |
| Gross Profit | $580,452 | -$876,019 | -$186,607 | $3,003,216 |
| % Margin | 70.4% | -253.8% | -18.1% | 69.8% |
| EBITDA | -$109,839 | -$1,645,686 | -$1,318,848 | $1,849,176 |
| % Margin | -13.3% | -476.8% | -127.9% | 43% |
| Net Income | -$378,884 | -$1,482,732 | -$909,431 | $1,914,390 |
| % Margin | -45.9% | -429.6% | -88.2% | 44.5% |
| EPS Diluted | -1.53 | -6.01 | -3.69 | 7.74 |
| % Growth | 74.5% | -62.9% | -147.7% | – |
| Operating Cash Flow | -$168,787 | -$916,252 | -$1,887,599 | $2,014,557 |
| Capital Expenditures | -$457,638 | -$610,470 | -$1,075,013 | -$1,203,136 |
| Free Cash Flow | -$626,425 | -$1,526,722 | -$2,962,612 | $811,421 |